Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.98% |
| Jun 30, 2025 | -78.43% |
| Mar 31, 2025 | -11.39% |
| Dec 31, 2024 | -12.03% |
| Sep 30, 2024 | -76.26% |
| Jun 30, 2024 | -78.52% |
| Mar 31, 2024 | -20.48% |
| Dec 31, 2023 | -16.34% |
| Sep 30, 2023 | -15.96% |
| Jun 30, 2023 | -14.64% |
| Mar 31, 2023 | -11.45% |
| Dec 31, 2022 | -2.77% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | 3.10% |
| Mar 31, 2022 | 56.23% |
| Dec 31, 2021 | 27.57% |
| Sep 30, 2021 | 25.71% |
| Jun 30, 2021 | 45.61% |
| Mar 31, 2021 | 52.66% |
| Dec 31, 2020 | 49.86% |